Thieler Law Corp advises investors with losses exceeding $100,000 of the March 8, 2019 lead plaintiff deadline in a class action lawsuit filed against Liberty Health Sciences Inc (OTC: LHSIF) (“Liberty” or “the Company”). The suit is pending in the U.S. District Court for the Southern District of New York and investors, who purchased Liberty Health Sciences Inc securities between June 28, 2018, and December 3, 2018, have until March 8, 2019 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Liberty Health Sciences Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that Liberty, in conjunction with Aphria, was involved in a scheme whereby numerous fraudulent acquisitions and transactions were made to provide undue benefits to both companies' insiders; and as a result, Liberty's public statements were materially false and misleading at all relevant times.

In September 2018, Liberty sold its stake in Aphria.

On December 3, 2018, a report by Quintessential Capital Management and Hindenburg Research entitled “Aphria: A Shell Game with a Cannabis Business on the Side,” revealed that Aphria was part of a scheme orchestrated by a network of insiders to divert funds away from shareholders and into their own pockets.

Following this news, OTC: LHSIF fell $0.36 per share, or nearly 34%, over the next two trading days to close at $0.70 on December 4, 2018.

If you were negatively impacted by your investment in Liberty Health Sciences Inc securities between June 28, 2018, and December 3, 2018 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185